Article Versions Notes

Patsali P, Mussolino C, Ladas P, Floga A, Kolnagou A, Christou S, Sitarou M, Antoniou MN, Cathomen T, Lederer CW, et al. The Scope for Thalassemia Gene Therapy by Disruption of Aberrant Regulatory Elements. Journal of Clinical Medicine. 2019; 8(11):1959. https://doi.org/10.3390/jcm8111959

Patsali, Petros, Claudio Mussolino, Petros Ladas, Argyro Floga, Annita Kolnagou, Soteroula Christou, Maria Sitarou, Michael N. Antoniou, Toni Cathomen, Carsten Werner Lederer, and et al. 2019. "The Scope for Thalassemia Gene Therapy by Disruption of Aberrant Regulatory Elements" Journal of Clinical Medicine 8, no. 11: 1959. https://doi.org/10.3390/jcm8111959

Patsali, P., Mussolino, C., Ladas, P., Floga, A., Kolnagou, A., Christou, S., Sitarou, M., Antoniou, M. N., Cathomen, T., Lederer, C. W., & Kleanthous, M. (2019). The Scope for Thalassemia Gene Therapy by Disruption of Aberrant Regulatory Elements. Journal of Clinical Medicine, 8(11), 1959. https://doi.org/10.3390/jcm8111959